Curtiss-Wright (NYSE: CW) insider transactions
In the twelve months to 10 November 2026, executives and directors of Curtiss-Wright reported 31 open-market sales of 47,276 shares ($30.1m) and 1 open-market purchase of 209 shares ($148,999), by 9 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 28 August 2026 | Wyche Larry D | Director | Open-market sale | −100 | $596.74 | 1,414 | Form 4 |
| 27 August 2026 | Watts John C | EVP & Chief Growth Officer | Open-market sale | −1,035 | $619.46 | 2,736 | Form 4 |
| 10 August 2026 | Lyash Jeffrey J. | Director | Open-market purchase | +209 | $711.62 | 257 | Form 4 |
| 6 July 2026 | Bamford Lynn M | Chair and CEO | Grant or award | +17 | $634.88 | 45,651 | Form 4 |
| 6 July 2026 | Farkas K Christopher | Executive VP and CFO | Grant or award | +21 | $634.88 | 4,274 | Form 4 |
| 6 July 2026 | Rayment Kevin | Executive VP and COO | Grant or award | +26 | $634.88 | 31,519 | Form 4 |
| 6 July 2026 | Watts John C | EVP & Chief Growth Officer | Grant or award | +9 | $634.88 | 3,771 | Form 4 |
| 6 July 2026 | McDonald George P. | Executive VP and Corporate Sec | Grant or award | +25 | $634.88 | 4,235 | Form 4 |
| 15 June 2026 | Watts John C | EVP & Chief Growth Officer | Open-market sale, 10b5-1 plan | −200 | $770.56 | 3,762 | Form 4 |
| 12 June 2026 | Bamford Lynn M | Chair and CEO | Open-market sale, 10b5-1 plan | −2,500 | $758.20 | 45,634 | Form 4 |
| 9 June 2026 | Bamford Lynn M | Chair and CEO | Open-market sale, 10b5-1 plan | −2,500 | $721.72 | 48,134 | Form 4 |
| 9 June 2026 | Ogilby Gary A | Senior VP & Corp Controller | Open-market sale, 10b5-1 plan | −399 | $721.95 | 2,172 | Form 4 |
| 1 June 2026 | Wallace Peter C | Director | Grant or award | +221 | $719.99 | 6,209 | Form 4 |
| 29 May 2026 | Minor Glenda J | Director | Grant or award | +20 | $747.61 | 2,491 | Form 4 |
| 27 May 2026 | Watts John C | EVP & Chief Growth Officer | Open-market sale, 10b5-1 plan | −220 | $752.91 | 3,962 | Form 4 |
| 12 May 2026 | Minor Glenda J | Director | Grant or award | +221 | $735.34 | 2,471 | Form 4 |
| 7 May 2026 | Lyash Jeffrey J. | Director | Grant or award | +48 | — | 48 | Form 4 |
| 18 March 2026 | Farkas K Christopher | Executive VP and CFO | Open-market sale, 10b5-1 plan | −1,265 | $689.69 | 4,253 | Form 4 |
| 18 March 2026 | Ogilby Gary A | Senior VP & Corp Controller | Open-market sale, 10b5-1 plan | −252 | $689.14 | 2,571 | Form 4 |
| 17 March 2026 | Bamford Lynn M | Chair and CEO | Open-market sale | −3,225 | $676.70 | 50,634 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Curtiss-Wright page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.